Treatment With Gamunex 10% Intravenous Immunoglobulin (IVIg) for Patients With Demyelination and Diabetes Mellitus: A Blinded, Placebo-Controlled Crossover Pilot Study
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Immunoglobulin G (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Therapeutic Use
- Acronyms IDIDM
- 10 Nov 2016 Planned End Date changed from 1 Feb 2017 to 1 Feb 2018.
- 10 Nov 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018.
- 04 Mar 2015 New trial record